A first-of-its-kind genomic study from India has revealed that the Mpox case detected in Kerala was caused by the Clade Ib variant imported through international travel from Dubai. Genetic sequencing traced the virus’s journey into India, uncovered dangerous mutations, and warned that this evolving strain may spread faster and wider through sustained human transmission.
Table of contents [Show]
The recent report about a new Mpox strain detected in Kerala is not just another infectious disease update. It represents a major scientific milestone for India because this is the first time a detailed genetic and genomic analysis has been used to understand how Mpox is evolving and spreading inside the country. According to the Times of India report and the supporting scientific publication, this is a first-of-its-kind study from India that does not merely confirm the presence of the virus but actually explains how the virus is changing, how it is travelling, and why it may become more dangerous in the future.
Until now, most Mpox reports in India and elsewhere were limited to simple case detection and confirmation. This new study, conducted by researchers from ICMR National Institute of Virology and VRDL laboratories across India, goes much deeper. Instead of stopping at diagnosis, the researchers performed full genetic sequencing of the virus, studied its mutations, analysed its evolutionary behaviour, and compared it with Mpox strains circulating in other parts of the world. This shift from routine testing to genomic investigation is what makes this study truly unique in the Indian context.
One of the most important findings of this genetic study is that the Kerala Mpox case was not caused by an older, already known strain, but by a newer Clade Ib variant. This particular clade has been responsible for recent outbreaks in parts of Africa and is considered more efficient in spreading among humans. The genetic analysis confirmed that the virus did not arise locally but was imported as part of a wider regional and international spread, most likely linked to travel. This directly supports the conclusion that the virus did not arrive through a single isolated carrier but is part of a much larger transmission network.
What makes this discovery more worrying is what the genetic data shows about the virus’s behaviour. The study found that this Mpox strain shows multiple mutations in genes related to symptoms, viral load, immune response, and transmission efficiency. In simple words, the virus is no longer behaving like the older Mpox strains we were familiar with. It is slowly adapting to humans and showing signs of sustained human to human transmission rather than remaining a rare animal to human infection.
Another extremely important contribution of this first-of-its-kind genetic study is the discovery that this new Clade Ib strain has significant changes in certain genes that are used in diagnostic PCR tests. The virus has developed deletions and mutations in specific regions of its genome, which means that some existing testing strategies may fail to correctly identify this new variant. This is a silent but serious danger, because a virus that escapes detection can continue spreading in the community without being noticed in time.
The Times of India report also highlights an important epidemiological finding from this study. When researchers analysed the travel history of recent Mpox patients, they found that most of them had international travel exposure. This clearly shows that the virus is no longer confined to one country or one region. Instead, it is moving across borders quietly, using human travel routes, and establishing itself in new populations. The Kerala case is therefore not an isolated medical event, but a warning sign of a broader regional and possibly global transmission pattern.
From a clinical point of view, this study is equally important. The patient from Kerala had extensive skin and genital lesions along with systemic symptoms and lymph node involvement, showing that this is not always a mild disease. The genetic profile of the virus suggests that future cases could present with more severe or more efficiently transmitted infections, especially if surveillance and early detection fail to keep pace with viral evolution.
The biggest lesson from this entire episode is that this is no longer the era of simple diagnosis alone. We are now in the era where genomic surveillance is essential. This first-of-its-kind Indian genetic study shows how modern medicine must track not just patients, but also the evolution of the virus itself. Without such studies, we would never know whether a virus is becoming more dangerous, more transmissible, or more capable of escaping our diagnostic tools.
In a larger public health context, this Kerala Mpox case shows exactly how future outbreaks and even pandemics begin. A virus evolves quietly in one region, spreads through travel networks, enters new countries unnoticed, and only gets detected when someone finally looks at its genetic makeup closely. This study has given India an early warning that should not be ignored.
For medical students and young doctors, this is a perfect real life example of how microbiology, virology, epidemiology, and public health all intersect. This is not just about Mpox. This is about how modern medicine must stay one step ahead of evolving pathogens. The Kerala Mpox case and this first-of-its-kind genetic study should be seen as a reminder that the next big outbreak will not announce itself loudly. It will arrive silently, through mutations, travel, and delayed detection.
Source:
Shete A M, Chenayil S, Sahay R R, Sindhu C B, Yadav P D et al. Genomic analysis confirmed the importation of first Mpox Clade Ib case in Kerala, India from Dubai, UAE, Journal of Infection, 2024.
Media coverage and contextual interpretation based on reporting by The Times of India.
ProtoRadNet, an explainable AI model developed at IISER Bhopal, can interpret MRI, CT and X ray scans like a radiologist. Built over 1.5 years and tested on public datasets with 92% accuracy and 190+ clinical reports, the system highlights suspicious regions and explains findings. This innovation could help address India’s radiologist shortage and improve diagnostic speed.
A major Indian Journal of Medical Research 2025 study reveals rising lung cancer incidence in India, sharp regional and gender disparities, increasing adenocarcinoma dominance, and worrying projections up to 2030.
A new Indian review reveals strong links between air pollution and heart disease, hypertension and stroke, urging urgent public health action and cleaner air policies.
